Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1CNS 1

Conditions

Neuroblastoma 44Ganglioneuroblastoma 6Brain Neoplasms 6Sarcoma 5Neoplasms 5Glioma 5Glioblastoma 5Central Nervous System Neoplasms 3Astrocytoma 3Optic Nerve Glioma 2Oligodendroglioma 2Neoplasm Metastasis 2Lymphoma, Non-Hodgkin 2Head and Neck Neoplasms 2Breast Neoplasms 2Bone Neoplasms 2Wilms Tumor 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma, Ewing 1Salivary Gland Neoplasms 1Rhabdoid Tumor 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pheochromocytoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neurofibrosarcoma 1Neurofibromatosis 1 1

Interventions

Docetaxel 8Radiotherapy 6Filgrastim 4Bevacizumab 4Paclitaxel 3Nivolumab 3Magnetic Resonance Spectroscopy 3Erlotinib Hydrochloride 3Cisplatin 3Cetuximab 3Carboplatin 3Capecitabine 3regorafenib 2pembrolizumab 2Radiotherapy, Intensity-Modulated 2Gemcitabine 2Cyclophosphamide 2Chemotherapy, Adjuvant 2Biopsy 2Acupuncture Therapy 2vandetanib 1tumor necrosis factor-alpha, CNGRC fusion protein, human 1tanespimycin 1spartalizumab 1sargramostim 1oncogene protein E7, Human papillomavirus type 16 1oblimersen 1fluoromisonidazole 1fludarabine phosphate 1etoposide phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Squamous Cell Carcinoma of Head and Neck × Doxorubicin × CNS × Clear all
NCT00509665 2018-07-12

Gemcitabine and Doxorubicin in Treating Patients With Recurrent or Progressive Head and Neck Cancer

Medical University of South Carolina

Phase 2 Completed
18 enrolled 9 charts
CNSHead & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Salivary Gland Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡